| Description | 1. Deoxyshikonin (Arnebin 7) may be a new drug candidate for wound healing and treatment of lymphatic diseases. 2. Deoxyshikonin enhances the ability of human dermal lymphatic microvascular endothelial cells (HMVEC-dLy) to undergo time-dependent in vitro cord formation. 3. Deoxyshikonin and dodecyl gallate show significantly synergic antimicrobial activity with penicillin in vivo and in vitro, and can effectively reduce nasopharyngeal and lung colonization caused by different penicillin-resistant pneumococcal serotypes. |
| Synonyms | 去氧紫草素, Arnebin 7 |
| molecular weight | 272.3 |
| Molecular formula | C16H16O4 |
| CAS | 43043-74-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 2.72 mg/mL (10 mM) |
| References | 1. Prangsaengtong O , Park J Y , Inujima A , et al. Enhancement of Lymphangiogenesis In Vitro via the Regulations of HIF-1 Expression and Nuclear Translocation by Deoxyshikonin[J]. Evidence-Based Complementary and Alternative Medicine, 2013, 2013:1-11. |